findmyKOL

Lakshmi Rao, DO

Basic profile

McLaren Macomb

ORCIDNone on fileNPI
RegionRoyal Oak, MI · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Lakshmi Rao is a Cardiology physician affiliated with McLaren Macomb. OpenAlex indexes 59 publications with 1,158 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
59publications

Distinct works indexed by OpenAlex.

1,158citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
36companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3601 W 13 Mile Rd
Royal Oak, MI 480736712

Telephone

248-898-4163

Provider last certified this registry record 1 Jul 2025.

View the NPPES registry record

Industry payments

36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.9%
    Statin22.1%
    Atorvastatin Calcium79%Rosuvastatin Calcium21%
    Part D<11 patients
    Beta blocker19.9%
    Metoprolol Succinate44%Metoprolol Tartrate30%Carvedilol27%
    Part D<11 patients

    + 6 more classes in this area

  • Blood & clotting

    18.4%
    P2Y12 inhibitor11.5%
    Clopidogrel70%Brilinta30%
    Part D<11 patients
    Factor Xa inhibitor6.9%
    Eliquis100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    3.7%
    SGLT2 inhibitor3.7%
    Jardiance100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”